Weizheng Xu

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Andrea Russo, Hyuk‐Chan Kwon, William Burgan et al. · Clinical Cancer Research · 2009 · 165 citations · Full text

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

Lucio Tentori, Pedro Miguel Lacal, Alessia Muzi et al. · European Journal of Cancer · 2007 · 146 citations

Angiogenesis, Natural Sciences, Pathology +5

PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy

Irina G. Obrosova, Weizheng Xu, Valeriy V. Lyzogubov et al. · Free Radical Biology and Medicine · 2007 · 109 citations · Full text

Parp Inhibition, Advanced Diabetic Neuropathy, Peripheral Nerve Injury +10

Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · The FASEB Journal · 2006 · 103 citations

Parp Inhibitor, Gastrointestinal Pharmacology, Gastroenterology +17